Global Legal Group日本药品广告分析 2009年+2010年

相似文件 换一批

是 否 +2 论坛币

k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群

赵安豆老师微信：zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

立即领取

感谢您参与论坛问题回答

经管之家送您两个论坛币！

+2 论坛币

The International Comparative Legal Guide to:Pharmaceutical Advertising 2009

1 General - Medicinal Products
1.1 What laws and codes of practice govern the advertising of
medicinal products in Japan?
In Japan, the “Pharmaceutical Affairs Law” (Law No. 145 of
August 10, 1960, as amended, inter alia, Articles 66-68) and the
“Standards for Fair Advertising Practices concerning Medicinal
Products” (Notice No. 1339 of October 9, 1970, by the Director-
General of the Pharmaceutical Affairs Bureau of the former
Ministry of Welfare) (“Standards for Fair Advertising Practices”)
define universally applicable baseline standards for marketing
practices with respect to medicinal products. As to self-regulation
in the pharmaceutical industry, there are a number of codes of
practice, including but not limited to, the “Code of Practices for
Promotion of Ethical Drugs” (established on March 24, 1993, by
Japan Pharmaceutical Manufactures Association (“JPMA”), as
amended) (the “Code of Practices”) and the “Fair Competition
Rules concerning Restriction on Provision of Unjustifiable
Premium in Manufacture of Ethical Drugs” (enforced on July 1,
1984, by the Fair Trade Council of the Ethical Pharmaceutical
Drugs Manufacturing Industry, as amended) (the “Fair Competition
Rules”). The Fair Competition Rules were established upon
certification by the Japan Fair Trade Commission in accordance
with the “Act against Unjustifiable Premiums and Misleading
Representation”.
1.2 How is “advertising” defined?

扫码加我 拉你入群

请注明：姓名-公司-职位

以便审核进群资格，未注明则拒绝

分享0 收藏0 回帖

关键词：Global lobal Legal Group Leg 日本 广告 药品